Author Index: R

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Rac, V. E.
• MIXED METHOD PROGRAM EVALUATION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ONTARIO, CANADA: QUALITATIVE STUDY

• THE ROLE OF TELEHOMECARE ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ONTARIO, CANADA

• NEW MODEL OF HEALTHCARE DELIVERY: TELEHOMECARE PROGRAM FOR HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN ONTARIO, CANADA

• DIAGNOSTIC ACCURACY OF LEVEL IV PORTABLE SLEEP TESTS VERSUS POLYSOMNOGRAPHY FOR SLEEP-DISORDERED BREATHING: A SYSTEMATIC REVIEW AND META-ANALYSIS

• COMPLEX INTERVENTIONS FOR COMPARATIVE EFFECTIVENESS AND HEALTH TECHNOLOGY ASSESSMENT – REAL WORLD EXPERIENCE
Rafia, R.
• THE COST-EFFECTIVENESS OF POTENTIAL IMPROVEMENTS IN THE DIAGNOSIS OF AND TREATMENT OF DEPRESSION AMONGST PEOPLE WITH DIABETES

• CONTINGENCY MANAGEMENT IMPROVES COMPLETION OF HEPATITIS B VACCINATION IN THOSE ON TREATMENT FOR OPIATE DEPENDENCE: AN ECONOMIC EVALUATION
Ratelle, J.
• INCREASING HIGH-VALUE VENOUS THROMBOEMBOLISM PROPHYLAXIS: A WIN-WIN SITUATION
Ray, J.
• ASSESSING THE CONTRIBUTION OF PATIENTS' PROXIMITY TO DEATH IN ECONOMIC EVALUATIONS IN PATIENTS WITH HER2+ METASTATIC BREAST CANCER: AN EVENT BASED ANALYSIS
Reimers, S.
• THE EFFECT OF THINKING TIME ON ATTRIBUTE NON-ATTENDANCE IN DISCRETE CHOICE EXPERIMENTS: AN EYE-TRACKING STUDY

• ANALYSIS OF EYE GAZE PATTERNS AND DECISION-MAKING STRATEGIES DURING A DISCRETE CHOICE EXPERIMENT
Renshaw-Fox, B.
• THE EFFECT OF EMPATHY ON RISK PERCEPTION FOR HEALTH VIGNETTES
Rentz, A.
• STRUCTURING BENEFIT-RISK MODELS IN PRESENCE OF NUMEROUS ADVERSE EVENTS: A CASE STUDY OF MULTIPLE SCLEROSIS
Ridd, M.
• SHARED DECISION MAKING IN ANTENATAL OBSTETRICS
Rideout, A.
• USING Q-METHODOLGY TO EXPLORE PRESCRIBING DECISION MAKING - A PROMISING APPROACH?
Rigby, D.
• PREFERENCES, EXPECTATIONS AND CAREER CHOICES: A BEST WORST SCALING STUDY OF JUNIOR DOCTORS' CHOICE OF SPECIALISM IN ENGLAND
Rivero-Arias, O.
• COMPARING ADOLESCENTS AND ADULT PREFERENCES TO EQ-5D-Y HEALTH STATES USING PROFILE CASE BEST-WORST SCALING
Robb, K.
• IMPROVING CANCER SCREENING INFORMATION: INSIGHTS FROM INDIVIDUAL DIFFERENCES IN INFORMATION PROCESSING
Robinson, M.
• THE IMPACT OF THE ALCOHOL ACT ON ALCOHOL-RELATED HEALTH HARMS IN SCOTLAND
Rochau, U.
• CLOSING CEREMONY AND AWARD PRESENTATIONS

• AN OVERVIEW OF DIFFERENT MAPPING TECHNIQUES TO DERIVE HEALTH STATE UTILITY VALUES IN MULTIPLE MYELOMA FOR DECISION-ANALYTIC MODELING

• COSTS OF FIRST-LINE TREATMENT FOR ELDERLY MULTIPLE MYELOMA PATIENTS WHO ARE NOT TRANSPLANT CANDIDATES IN THE SERBIAN HEALTH CARE SYSTEM

• META-ANALYSIS AND INDIRECT TREATMENT COMPARISON OF SAFETY PROFILES OF BORTEZOMIB- AND THALIDOMIDE-BASED REGIMENS FOR THE FIRST LINE TREATMENT OF ELDERLY TRANSPLANT-INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA

• TREATMENT STRATEGIES FOR MULTIPLE MYELOMA IN ELDERLY PATIENTS: A NETWORK META-ANALYSIS
Rockall, A.
• PREDICTORS OF PATIENT PREFERENCES FOR WHOLE BODY MAGNETIC RESONANCE IMAGING COMPARED WITH STANDARD STAGING PATHWAYS FOR THE INVESTIGATION OF SYMPTOMS OF SUSPECTED COLORECTAL OR LUNG CANCER
Rockliffe, L.
• A SYSTEMATIC REVIEW OF ETHNICITY-SPECIFIC FACTORS INFLUENCING CHILDHOOD IMMUNISATION DECISIONS AMONG BLACK AND ASIAN MINORITY ETHNIC GROUPS IN THE UK
Rosthoej, S.
• DIAGNOSING QUALITY OF TREATMENT FROM SURVIVAL TIMES
Rothery, C.
• RESOURCE ALLOCATION DECISIONS AND BUDGETARY POLICIES UNDER CONDITIONS OF UNCERTAINTY
Rue, M.
• PROBABILISTIC SENSITIVITY ANALYSIS OF COST-EFFECTIVENESS ANALYSIS OF THE BREAST CANCER SCREENING PROGRAMME IN THE BASQUE COUNTRY: A MULTI-COHORT DISCRETE-EVENT SIMULATION MODEL
Ryan, W.
• THE ROLE OF TELEHOMECARE ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ONTARIO, CANADA

• NEW MODEL OF HEALTHCARE DELIVERY: TELEHOMECARE PROGRAM FOR HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN ONTARIO, CANADA
Ryder, S. D.
• WHEN AND WHERE IN THE TREATMENT PATHWAY IS IT APPROPRIATE TO USE NEW DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C?
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z